$PEPTIDES · On Solana
$PEPTIDES · On Solana
Market Opportunity
Historical market size · Bull case projection to 2045
Bull case anchored on Grand View Research's $294.58B by 2033 at 8.73% CAGR, extended with accelerating adoption driven by GLP-1 expansion, AI-assisted peptide design, oral delivery breakthroughs, and convergence of therapeutics, synthesis, nutraceutical, and cosmeceutical segments. Analyst range: Precedence Research (conservative) to Grand View Research (aggressive). Projections beyond 2033 are speculative extrapolations, not published forecasts.
The Community